Stefano Fregoni

30 Added | 1 Magazine | 19 Following | 447 Followers | @StefanoFregoni | Keep up with Stefano Fregoni on Flipboard, a place to see the stories, photos, and updates that matter to you. Flipboard creates a personalized magazine full of everything, from world news to life’s great moments. Download Flipboard for free and search for “Stefano Fregoni”

Novartis and GSK to exchange assets and launch joint venture

<b>Novartis and GlaxoSmithKline, two of the world's top drugmakers, have struck a multi-billion-dollar deal to join forces and reshape their businesses.</b><p>The deal involves swapping assets and combining their consumer health units.<p>Novartis will acquire GSK's cancer drugs business for $16bn (£9.5bn) and …

Bill Ackman

Big Pharma Opens New Chapter On Big Data Collaboration

In the course of one short week, no less than 3 different models have emerged for sharing big data in the pharmaceutical industry.<p>The highest profile of these ‒ called Project Data Sphere (PDS here) ‒ was announced earlier today with the official opening of an online resource to share clinical …

Sorry - Server error

The website encountered an error while retrieving your page.

Europe Moves to Make Drug Trial Data More Transparent

Drug researchers in Europe would be required to publish results from all medical trials under a proposed law that the European Parliament will vote …

GSK links with top labs on 'big data' drug project | Reuters

LONDON (Reuters) - GlaxoSmithKline is linking with two top bioscience centres on an open-access research project to tap into “big data” generated by gene research, in a move highlighting how drug companies are learning to share.<p>The new public-private Centre for Therapeutic Target Validation (CTTV) …

Valeant to Acquire PreCision

Shutterstock photo<p>In a bid to further strengthen its dermatology portfolio, <b>Valeant Pharmaceuticals International, Inc.</b> ( VRX ) entered into a …

Novartis CEO tempers talk of Roche stake sale | Reuters

DAVOS, Switzerland (Reuters) - Novartis Chief Executive Joe Jimenez played down talk that it was looking to sell its one-third voting stake in crosstown rival Roche, and certainly not at its current market price.<p>There has been widespread speculation that the Novartis could be heading for a change …

U.S. to announce trade enforcement action linked to India | Reuters

NEW DELHI (Reuters) - The United States will on Monday announce a trade enforcement action linked to India, potentially dealing another blow to bilateral relations damaged in December by the arrest and strip-search of an Indian consul.<p>A guest holds the flags of the United States and India and a …

CVS Caremark pharmacies to halt tobacco sales

<b>CVS Caremark, one of the largest pharmacy chains in the US, will stop selling cigarettes and other tobacco products, its chief executive has said.</b><p>The announcement drew swift praise from President Barack Obama, who said the move would save lives.<p>The 7,600 CVS shops in the US will have tobacco …

CVS Health

Teva Acquisition Machine Gears Up: Who Is the Next Target?

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) shares recently hit a 52-week high after the chief financial officer of the maker of generic …

Big Pharma pushes for U.S. action against India over patent worries | Reuters

MUMBAI/LONDON (Reuters) - Global pharmaceutical firms are pressuring the United States to act against India to stop more local companies producing up to a dozen new varieties of cheap generic drugs still on-patent, sources with direct knowledge of the matter said.<p>A private security guard looks out …

Pharma data play larger role in anti-doping effort | U.S. News | US News

By MATTHEW PERRONE, AP Health Writer<p>WASHINGTON (AP) — Some of the world's biggest drugmakers are playing a larger role in anti-doping efforts at this …

Stock Markets

GSK to launch late-stage clinical trials on 10 new drugs: paper | Reuters

(Reuters) - GlaxoSmithKline is set to unveil plans to launch late-stage clinical trials on 10 new drugs over the next two years, the Telegraph reported, without citing sources.<p>The GlaxoSmithKline building is pictured in Hounslow, west London June 18, 2013. REUTERS/Luke MacGregor<p>The new drugs, which …

Bristol-Myers Squibb Completes Previously Announced Sale of Global Diabetes Business to AstraZeneca

NEW YORK, Feb 03, 2014 (BUSINESS WIRE) -- Bristol-Myers Squibb Company BMY, -2.29% today announced that it has completed the previously announced …

Biotechnology

The Bristol-Myers Squibb Co. Overreaction Highlights The Dependence On Oncology

Immuno-oncology is set to be a huge market, and one that is hugely important to Bristol-Myers' future.<p>After years of the big pharma industry pushing …

Novartis Profit Drops on Currencies in Emerging Markets

Novartis AG, Europe’s biggest drugmaker by sales, said fourth-quarter profit fell as currencies in emerging markets weakened against the …

Drug Patent Expirations Continue To Hit Pfizer Revenue

Generic versions of name-brand medicines might help consumers keep money in their wallets, but consumers’ gains are proving to be nothing but pain for companies like Pfizer, whose revenues have continued to get hit by the expiration of patents for some of its most valuable brands.<p>The global drug …

GW Pharma shares have been halted since this morning

Apr 19, 2018<br>12:35 PM<p>The Dow Jones Industrial Average on Thursday was trading near the lows of the session as a steady rise in the rates of long-dated Treasurys weighed on buying appetite for stocks. The 10-year Treasury note yield was hitting its highest level since Feb. 23, around 2.93%, according …

Stock Markets

Pfizer sales decline on increased competition from generics

Pfizer reported better than expected fourth-quarter profit on Tuesday, but revenues fell as the maker of Lipitor and Viagra faced increased …

Biotechnology

J&J Sets Drug Data Free in ‘YODA’ Collaboration With Yale

Johnson & Johnson will give academics access to data on clinical trials, a move that may prompt more companies to do the same.<p>The collaboration with …

J&J Escapes $482 Million Jury Verdict Over Heart Devices

The U.S. Supreme Court refused to revive a $482 million jury verdict against Johnson & Johnson over disputed heart devices, rejecting an appeal by a …

In Stunning Win For Open Science, Johnson & Johnson Decides To Release Its Clinical Trial Data To Researchers

Drug companies tend to be secretive, to say the least, about studies of their medicines. For years, negative trials would not even be published. Except for the U.S. Food and Drug Administration, nobody got to look at the raw information behind those studies. The medical data behind important drugs, …

Why Big Pharma Companies Need to Collaborate

<b>Bristol-Myers Squibb</b> and <b>AstraZeneca</b> made waves last month after announcing that their partnership in the diabetes space has come to an end; …

Will Big Pharmas Continue to Outperform?

Investors looking for growth in the health-care sector often neglect the major pharmas in favor of their smaller counterparts. The idea is simple …